STOCK TITAN

Planned Rule 144 sale at issuer (NASDAQ: RAPP) totals 17,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

David S. Bredt filed a notice of proposed sale under Rule 144 to sell 17,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. The filing lists an aggregate market value of $466,140.00 for these shares and notes that 47,661,138 shares of the issuer’s common stock are outstanding.

The shares to be sold were acquired as founder shares on 03/09/2023, with 17,000 securities acquired and paid for on the same date. Over the past three months, related sales of common stock by David S. Bredt include 6,567 shares sold on 12/31/2025 for $197,337.69, 8,500 shares sold on 12/15/2025 for $255,130.05, and 8,500 shares sold on 11/17/2025 for $214,090.35, with two of these transactions identified as Rule 10b5-1 sales.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many RAPP shares are planned to be sold under this Rule 144 filing?

The notice states that 17,000 shares of common stock are planned to be sold under Rule 144.

What is the aggregate market value of the RAPP shares to be sold?

The filing lists an aggregate market value of $466,140.00 for the 17,000 shares of common stock to be sold.

Which broker and exchange are involved in this RAPP Rule 144 sale?

The planned sale is through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

When were the RAPP shares to be sold under Rule 144 originally acquired?

The 17,000 common shares to be sold were acquired as founder shares on 03/09/2023, with payment made on the same date.

How many RAPP shares has David S. Bredt sold in the past three months?

The filing lists sales of 6,567 shares on 12/31/2025, 8,500 shares on 12/15/2025, and 8,500 shares on 11/17/2025, all in common stock.

Are any of the recent RAPP share sales under a Rule 10b5-1 trading plan?

Yes. The sales of 8,500 shares on 12/15/2025 and 8,500 shares on 11/17/2025 are identified as 10b5-1 sales for David S. Bredt.

How many RAPP common shares are outstanding according to this filing?

The filing states that 47,661,138 shares of the issuer’s common stock are outstanding.

Rapport Therapeutics Inc

NASDAQ:RAPP

RAPP Rankings

RAPP Latest News

RAPP Latest SEC Filings

RAPP Stock Data

1.28B
45.04M
6.26%
106.26%
8.62%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON